Definitive Contract 70CDCR26C00000005
- Not listed
- The U.S. National Park Service awarded a $19,185.00 firm-fixed-price purchase order to FFF Enterprises, Inc. to provide anti-venin for the Yosemite National Medical Clinic at Yosemite National Park. The contract has an ultimate completion date of April 25, 2024. FFF Enterprises, Inc. is a national specialty distributor of critical care biopharmaceuticals, plasma products, and vaccines, and has a history of providing pharmaceutical products and medical supplies to various federal agencies,...
- This is a $9,248.16 firm-fixed-price delivery order contract awarded by the Federal Medical Center Devens, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in influenza vaccine manufacturing and supply. The contract is for the delivery of influenza virus vaccines to the FMC Devens staff and inmate population, with 50% of the requirements to be shipped between August 15, 2025, and September 15, 2025, and the remaining 50% delivered on or...
- This federal contract award is for the supply of Seqirus influenza vaccines to the Federal Correctional Institution (FCI) in Bastrop, Texas. The contract, valued at $3,541.14, is a firm-fixed-price delivery order awarded to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The contract supports the annual flu vaccination program for federal inmates...
- This is a $2,938.20 firm-fixed-price delivery order contract awarded by the Federal Correctional Institution Big Spring, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the supply of influenza vaccines for the 2025-2026 flu season, with an ultimate completion date of October 15, 2025. The award is not designated as a set-aside contract. Seqirus USA Inc. is a global biotechnology company that specializes in the development,...
- The U.S. Federal Correctional Institution Maxwell awarded a firm-fixed-price purchase order to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the delivery of AFLURIA Trivalent or Quadrivalent multi-dose vials and FLUAD Trivalent or Quadrivalent pre-filled syringes. The contract has a ceiling value of $2,914.14 and an ultimate completion date of April 11, 2025. Seqirus USA Inc. is a leading provider of influenza vaccines to various federal government agencies,...
- This is a federal contract awarded by the Federal Correctional Complex Lompoc, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods. The contract, with a ceiling value of $18,612.00, is for the delivery of Influenza Virus Vaccine for the 2025-2026 season under a mandatory national contract. The contract is a firm-fixed-price delivery order with an ultimate completion date of September 30, 2025. Seqirus USA Inc. is the prime contractor and does not have any...
- Immigration and Customs Enforcement (ICE) awarded North East South West Healthcare Solutions LLC a $25,000 firm fixed-price delivery order against its ICE Medical Staffing Services indefinite-delivery, indefinite-quantity (IDIQ) multiple award contract. This guaranteed minimum order will be performed in McLean, Virginia from September 1, 2023 through August 31, 2028 to provide medical staffing services in support of ICE programs. The prime contractor will draw from the ICE Medical Staffing...
- This is a firm-fixed-price delivery order contract awarded by the Metropolitan Detention Center Los Angeles, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods. The contract, valued at $1,844.82, is for the delivery of flu vaccines to the agency. This contract does not utilize a set-aside designation. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal...
- This is a firm-fixed-price delivery order contract awarded by the Federal Correctional Institution El Reno, a civilian agency, to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of FY25 SEQIRUS INFLUENZA VACCINE with a ceiling value of $3,102.00 and a completion date of October 15, 2025. Seqirus USA Inc. is a leading manufacturer of influenza vaccines and has been awarded numerous federal contracts to supply vaccines to various government...
- This is a $2,326.50 firm-fixed-price delivery order awarded by the United States Penitentiary Atlanta, a civilian federal agency, to Seqirus USA Inc., a foreign-owned, for-profit biotechnology manufacturer, for the supply of flu vaccines for staff and inmates in 2025. The contract does not utilize a set-aside designation. Seqirus USA Inc. is a registered federal contractor that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government...
The U.S. Immigration and Customs Enforcement (ICE) awarded a definitive contract valued at $616,000 to FFF Enterprises, Inc. on December 17, 2025, for the provision of vaccine products to the ICE Health Service Corps. The contract, which carries a firm fixed-price structure and no set-aside designation, is scheduled for completion by June 16, 2026, with performance taking place at FFF Enterprises' facility in Temecula, California. FFF Enterprises, Inc. is a national specialty distributor of critical care biopharmaceuticals, plasma products, and vaccines with an established track record in the federal pharmaceutical supply chain dating back to 2001. The company regularly supplies medications and medical products to multiple federal agencies, including the Department of Veterans Affairs, Bureau of Prisons, National Park Service, and National Institutes of Health. This contract reflects FFF Enterprises' demonstrated capability to serve ICE's healthcare operations through reliable vaccine procurement and distribution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $308.0k | 12/17/25 |